28 Jul 2017 --- The formal adoption of the EU Regulatory Committee on Medical Devices’ “cranberry decision” on cranberry products that are intended to prevent or treat cystitis is expected imminently. The decision is expected to come into effect this summer and means that “cranberry products currently sold as medical devices will have to be re-categorized either as dietary supplements or drugs,” Dr. Iris Hardewig, Consulting & Strategic Innovation Senior Consultant at consulting and CRO services company analyze & realize, tells NutritionInsight.
